[Obliterating agents, their toxicity and mode of action].
D000818:Animals; D003902:Detergents / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006982:Hypertonic Solutions / Q000627:therapeutic use; D007038:Hypotonic Solutions / Q000627:therapeutic use; D007866:Leg / Q000098:blood supply; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000627:therapeutic use; D014648:Varicose Veins / Q000188:drug therapy*
D003902:Detergents; D006982:Hypertonic Solutions; D007038:Hypotonic Solutions; D012597:Sclerosing Solutions; D013501:Surface-Active Agents
Leki obliterujace, ich toksyczność i sposób działania.